RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Bioporto A/S P/S 2024

Bioporto A/S P/S

14.38

Bioporto A/S Dividend yield

Ticker

BIOPOR.CO

ISIN

DK0011048619

WKN

893191

As of May 31, 2024, Bioporto A/S's P/S ratio stood at 14.38, a -2.24% change from the 14.71 P/S ratio recorded in the previous year.

The Bioporto A/S P/S history

Bioporto A/S Aktienanalyse

What does Bioporto A/S do?

Bioporto A/S is a Danish company specializing in the development, production, and sale of diagnostic products for use in medical diagnostics. It was founded in 1999 and is headquartered in Hellerup, near Copenhagen. The company's history is closely connected to the development and marketing of biomarkers and tests. Biomarkers are biological substances that can serve as indicators for certain diseases or health conditions. Bioporto A/S specializes in the identification and development of these biomarkers, playing an important role in medical diagnostics. Its business model is based on the development and production of medical diagnostic products based on the identification of biomarkers. The company focuses on various sectors such as clinical diagnostics, the life science industry, and research and development in the diagnostic field. Bioporto A/S offers a wide range of products that cater to different customer needs. In the field of clinical diagnostics, the company provides a variety of tests and test kits for the identification of biomarkers. These include tests for determining N-terminal prohormones of brain natriuretic peptides (NT-proBNP), a biomarker used in the diagnosis of heart failure, as well as tests for detecting protein C and S, hormone receptors, or Addison's disease. In the life science industry, Bioporto A/S offers products used in the exploration of biomarkers, antibodies, and proteins. This includes antibodies that can be used for protein and protein complex analysis. Research and development of new biomarkers and diagnostic products are of great importance at Bioporto A/S. The company continually invests in the development of new tests and test kits to expand its product range and meet the ever-growing demands of medical diagnostics. Overall, Bioporto A/S is an innovative company playing an important role in medical diagnostics. With its high-quality products and close collaboration with partners in research and development, Bioporto A/S ensures it will continue to play a significant role in the identification and development of biomarkers and diagnostic products in the future. Bioporto A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Bioporto A/S's P/S Ratio

Bioporto A/S's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Bioporto A/S's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Bioporto A/S's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Bioporto A/S’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Bioporto A/S Stock

What is the price-to-earnings ratio of Bioporto A/S?

The price-earnings ratio of Bioporto A/S is currently 14.38.

How has the price-earnings ratio of Bioporto A/S changed compared to last year?

The price-to-earnings ratio of Bioporto A/S has increased by -2.24% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Bioporto A/S high compared to other companies?

Yes, the price-to-earnings ratio of Bioporto A/S is high compared to other companies.

How does an increase in the price-earnings ratio of Bioporto A/S affect the company?

An increase in the price-earnings ratio of Bioporto A/S would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Bioporto A/S affect the company?

A decrease in the price-earnings ratio of Bioporto A/S would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Bioporto A/S?

Some factors that influence the price-earnings ratio of Bioporto A/S are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Bioporto A/S pay?

Over the past 12 months, Bioporto A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioporto A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bioporto A/S?

The current dividend yield of Bioporto A/S is .

When does Bioporto A/S pay dividends?

Bioporto A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bioporto A/S?

Bioporto A/S paid dividends every year for the past 0 years.

What is the dividend of Bioporto A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bioporto A/S located?

Bioporto A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bioporto A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bioporto A/S from 5/31/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Bioporto A/S pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Bioporto A/S in the year 2023?

In the year 2023, Bioporto A/S distributed 0 DKK as dividends.

In which currency does Bioporto A/S pay out the dividend?

The dividends of Bioporto A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bioporto A/S

Our stock analysis for Bioporto A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioporto A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.